Literature DB >> 12407443

Cooperation of hTERT, SV40 T antigen and oncogenic Ras in tumorigenesis: a cell transplantation model using bovine adrenocortical cells.

Michael Thomas1, Tetsuya Suwa, Lianqing Yang, Lifang Zhao, Christina L Hawks, Peter J Hornsby.   

Abstract

Expression of TERT, the reverse transcriptase component of telomerase, is necessary to convert normal human cells to cancer cells. Despite this, "telomerization" by hTERT does not appear to alter the normal properties of cells. In a cell transplantation model in which bovine adrenocortical cells form vascularized tissue structures beneath the kidney capsule in scid mice, telomerization does not perturb the functional tissue-forming capacity of the cells. This cell transplantation model was used to study the cooperation of hTERT with SV40 T antigen (SV40 TAg) and oncogenic Ras in tumorigenesis. Only cells expressing all three genes were tumorigenic; this required large T, but not small t, antigen. These cells produced a continuously expanding tissue mass; they were invasive with respect to adjacent organs and eventually destroyed the kidney. Cells expressing only hTERT or only Ras produced minimally altered tissues. In contrast, SV40 TAg alone produced noninvasive nodules beneath the kidney capsule that had high proliferation rates balanced by high rates of apoptosis. The use of cell transplantation techniques in a cell type that is able to form tissue structures with or without full neoplastic conversion allows the phenotypes produced by individual cooperating oncogenes to be observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12407443      PMCID: PMC1503663          DOI: 10.1038/sj.neo.7900262

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  42 in total

1.  TIN2, a new regulator of telomere length in human cells.

Authors:  S H Kim; P Kaminker; J Campisi
Journal:  Nat Genet       Date:  1999-12       Impact factor: 38.330

2.  The catalytic subunit of telomerase protects neurons against amyloid beta-peptide-induced apoptosis.

Authors:  H Zhu; W Fu; M P Mattson
Journal:  J Neurochem       Date:  2000-07       Impact factor: 5.372

3.  The use of telomerized cells for tissue engineering.

Authors:  J W Shay; W E Wright
Journal:  Nat Biotechnol       Date:  2000-01       Impact factor: 54.908

4.  Telomerase expression restores dermal integrity to in vitro-aged fibroblasts in a reconstituted skin model.

Authors:  W D Funk; C K Wang; D N Shelton; C B Harley; G D Pagon; W K Hoeffler
Journal:  Exp Cell Res       Date:  2000-08-01       Impact factor: 3.905

Review 5.  Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology.

Authors:  W E Wright; J W Shay
Journal:  Nat Med       Date:  2000-08       Impact factor: 53.440

Review 6.  The structural and mechanical complexity of cell-growth control.

Authors:  S Huang; D E Ingber
Journal:  Nat Cell Biol       Date:  1999-09       Impact factor: 28.824

7.  Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells.

Authors:  B Elenbaas; L Spirio; F Koerner; M D Fleming; D B Zimonjic; J L Donaher; N C Popescu; W C Hahn; R A Weinberg
Journal:  Genes Dev       Date:  2001-01-01       Impact factor: 11.361

Review 8.  Changes in gene expression during senescence of adrenocortical cells in culture.

Authors:  P J Hornsby; C Y Cheng; D S Lala; S S Maghsoudlou; S G Raju; L Yang
Journal:  J Steroid Biochem Mol Biol       Date:  1992-12       Impact factor: 4.292

9.  Genetic and epigenetic changes in human epithelial cells immortalized by telomerase.

Authors:  D G Farwell; K A Shera; J I Koop; G A Bonnet; C P Matthews; G W Reuther; M D Coltrera; J K McDougall; A J Klingelhutz
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

10.  Extension of cell life-span and telomere length in animals cloned from senescent somatic cells.

Authors:  R P Lanza; J B Cibelli; C Blackwell; V J Cristofalo; M K Francis; G M Baerlocher; J Mak; M Schertzer; E A Chavez; N Sawyer; P M Lansdorp; M D West
Journal:  Science       Date:  2000-04-28       Impact factor: 47.728

View more
  6 in total

Review 1.  Improving cell therapy--experiments using transplanted telomerase-immortalized cells in immunodeficient mice.

Authors:  Qin Huang; Meizhen Chen; Sitai Liang; Victor Acha; Dan Liu; Furong Yuan; Christina L Hawks; Peter J Hornsby
Journal:  Mech Ageing Dev       Date:  2006-11-22       Impact factor: 5.432

2.  The role of protein tyrosine phosphatase 1B in Ras signaling.

Authors:  Nadia Dubé; Alan Cheng; Michel L Tremblay
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-06       Impact factor: 11.205

Review 3.  New directions for the treatment of adrenal insufficiency.

Authors:  Gerard Ruiz-Babot; Irene Hadjidemetriou; Peter James King; Leonardo Guasti
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-06       Impact factor: 5.555

Review 4.  A prospect of cell immortalization combined with matrix microenvironmental optimization strategy for tissue engineering and regeneration.

Authors:  Yiming Wang; Song Chen; Zuoqin Yan; Ming Pei
Journal:  Cell Biosci       Date:  2019-01-05       Impact factor: 7.133

5.  Establishment and evaluation of a PRRSV-sensitive porcine endometrial epithelial cell line by transfecting SV40 large T antigen.

Authors:  Kang Zhang; Houshen Li; Shasha Dong; Ying Liu; Dong Wang; Haichang Liu; Feng Su; Lijiang Ge; Yunliang Jiang
Journal:  BMC Vet Res       Date:  2019-08-19       Impact factor: 2.741

6.  Acquisition order of Ras and p53 gene alterations defines distinct adrenocortical tumor phenotypes.

Authors:  Maryline Herbet; Aude Salomon; Jean-Jacques Feige; Michaël Thomas
Journal:  PLoS Genet       Date:  2012-05-10       Impact factor: 5.917

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.